Frontline Cardiology 2019: Cardiovascular Care in the Community

Saturday, May 18, 2019, 7:00 AM - 4:00 PM EST, College Park Marriott Hotel and Conference

Online registration is now closed. 

We will start on-site registration at 7:00 am.

Cardiovascular disease remains the leading cause of morbidity and mortality in the United States. New treatment strategies, medications and device developments in multiple areas of cardiovascular disease intend to afford benefit to the millions of patients who suffer from these conditions. Given the rapid progress in cardiovascular medicine, it can be difficult for frontline providers to keep abreast of changes in preventive cardiology, pharmacotherapy, new innovative therapeutic procedures, diagnostic methods and new technologies. There are also many sources of information that people are learning from. It is important to provide a forum in which practicing healthcare providers are presented with new information in a way that establishes a common knowledge base. This course aims to shorten the translation from evidence to practice on a wide variety of cardiovascular issues including preventive cardiology, diagnostic methods, new innovative therapies and procedures. This meeting will bring together diverse members of the interdisciplinary practice team, towards creating a common knowledge base so important to effectiveness of the care team in today's practice environment.

1. Identify patients at risk for CVD and implement strategies to improve practice in cardiovascular prevention including risk factor modification lipid therapy
2. Identify alternatives to antiplatelet and anticoagulants in CAD and atrial fibrillation among patients who may benefit from these therapies
3. Utilize new technologies such as handheld ultrasound devices to evaluate the presence of CVD
4. Review the latest advances in heart failure treatment strategies and describe novel therapies for infiltrative cardiomyopathies
5. Recognize signs of pulmonary hypertension in patients in the community, list diagnostic strategies and describe therapeutic options for pulmonary hypertension
6. Define myocardial infarction and describe implications for ambulatory evaluation and management.
7. Increase ability to counsel patients for advances in cardiovascular practice such as anticoagulants, lipid lowering therapies and cardiovascular risk lowering medications in CAD
8. Identify indications for cardiac CT in CVD risk stratification and diagnosis
9. Recognize and describe novel valve therapies

Physician	$75
Resident or Fellow	$40
Physician Assistant	$40
Nurse Practitioner	$40
Nurse	$40
Allied Health	$40

Accreditation
In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 6.75 Interprofessional Continuing Education (IPCE) credits for learning and change.

This Live activity, Frontline Cardiology 2019: Cardiovascular Care in the Community, with a beginning date of 5/18/2019, has been reviewed and is acceptable for up to 6 Prescribed credits by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ Physician (6.75 hours), IPCE (6.75 hours), Non-Physician Member of the Healthcare Team (6.75 hours), Nurse - ANCC (6.75 hours)

College Park Marriott Hotel and Conference Center
3501 University Blvd East
Hyattsville, MD

Mitigation of Relevant Financial Relationships

MedStar Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.

Individuals in a position to control the content of this CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships listed below have been mitigated prior to the commencement of the activity.

Saturday, May 18, 2019

Exhibitor opportunities are available for this conference. Please contact Ada Guo for more information at [email protected] or 202-780-1704.